Clinical Trial Update: Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating MOAP regimen as rescue therapy for relapsed/refractory Hodgkin lymphoma after DP regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• MOAP regimen

Snippet

Sponsor: Han weidong | Conditions: Hodgkin Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN